Essential Laboratory Tests for 60-Year-Old Females in Primary Care
For a 60-year-old female patient in primary care, essential laboratory tests should include a comprehensive metabolic panel, fasting lipid profile, thyroid function tests, fasting blood glucose or HbA1c, complete blood count, and age-appropriate cancer screening tests.
Core Laboratory Tests
Metabolic and Cardiovascular Assessment
Comprehensive metabolic panel 1
- Includes electrolytes, kidney function (BUN, creatinine), liver function tests
- Albumin level
- Calcium, magnesium levels
Fasting lipid profile 2
- Total cholesterol (target <200 mg/dL)
- HDL cholesterol (target >50 mg/dL)
- LDL cholesterol (target <100 mg/dL)
- Triglycerides (target <150 mg/dL)
- Recommended every 4-6 years for women aged 20-79 years
Blood pressure measurement 2
- Target <120/80 mmHg
- Elevated BP defined as 120-129/<80 mmHg
- Stage 1 hypertension: 130-139/80-89 mmHg
- Stage 2 hypertension: ≥140/90 mmHg
Diabetes Screening
- Fasting blood glucose or HbA1c 2
- Target values: fasting glucose <100 mg/dL or HbA1c <5.7%
- Particularly important for women who are overweight (BMI ≥25 kg/m²) or have additional risk factors
- Repeat testing at minimum 3-year intervals if results are normal
Hematologic Assessment
- Complete blood count with differential 1
- Screens for anemia, infection, and other hematologic abnormalities
Thyroid Function
- Thyroid stimulating hormone (TSH) 2
- Especially important with symptoms of thyroid dysfunction
Urinalysis
- Urinalysis 2
- Screens for kidney disease and urinary tract infections
- Checks for RBC, WBC, protein levels, and sediment
Cancer Screening Tests
Colorectal Cancer Screening
- Fecal occult blood test (FOBT) or fecal immunochemical test (FIT) 2
- Annual testing recommended beginning at age 50
- Alternatives include flexible sigmoidoscopy every 5 years, colonoscopy every 10 years, or CT colonography every 5 years
Breast Cancer Screening
- Mammography 2
- Annual screening recommended beginning at age 40
- Clinical breast examination recommended annually
Cervical Cancer Screening
- Pap smear 1
- Annual testing in women after 2 normal Pap tests documented during the first year after HIV diagnosis
- Can be stopped for women aged 70+ who have had 3 or more normal Pap tests and no abnormal Pap tests within the last 10 years
Additional Tests Based on Risk Factors
Bone Health
- Bone densitometry 1, 2
- Recommended for women aged 65 years and older
- Consider earlier for perimenopausal women with risk factors for premature bone loss (low body weight, family history, smoking, decreased physical activity)
Infectious Disease Screening
- STI screening 2
- Including gonorrhea and chlamydia testing if sexually active or at risk
- HIV testing 2
- At least once for all adults
- Hepatitis B screening 2
- For women at high risk
Mental Health
- Depression screening 2
- Using standardized screening tools
Obesity-Related Testing
For patients with BMI ≥30 kg/m² or ≥25 kg/m² with obesity-related conditions:
- Additional metabolic assessments 1:
- Liver function tests
- Consider calculation of Fibrosis-4 Index for nonalcoholic fatty liver disease
- Screening for obstructive sleep apnea (clinical questionnaires like STOP-BANG)
Common Pitfalls and Caveats
Overscreening in low-risk patients: Evidence does not support comprehensive annual examinations for all asymptomatic adults. Focus should be on evidence-based, age-appropriate screening 2.
Underscreening in high-risk patients: Patients with higher BMI or age are typically screened more often, but some obese patients may be under-screened for diabetes and dyslipidemia 3.
Gender disparities: Women are sometimes screened at lower rates than men for certain conditions 3, so ensure equal attention to screening protocols.
Hypoglycemia risk: When treating diabetes in older adults, be cautious about tight glycemic control as hypoglycemia can increase risk of falls, cognitive impairment, and cardiac arrhythmias 4, 5.
Balancing benefits and risks: For older patients, consider the balance between benefits of screening and potential harms of subsequent interventions, particularly when life expectancy is limited 5.
By following these guidelines for laboratory testing in 60-year-old female patients, primary care providers can effectively screen for common conditions affecting this population and optimize health outcomes.